Value proposition

Providing minimally-invasive options for the treatment of end-stage chronic limb-threatening ischemia (CLTI)

LimFlow SA, part of Inari Medical, Inc., is a leading provider of medical technology that provides new hope to patients suffering from the most severe form of peripheral artery disease, Chronic Limb-Threatening Ischemia (CLTI), and who are facing the prospect of amputation.

LimFlow is revolutionizing healthcare by offering a breakthrough solution for end-stage CLTI patients when traditional treatments fall short. Using an innovative percutaneous procedure, the LimFlow System reinvents anatomy to restore blood flow to the ischemic foot, which aims to alleviate pain, foster wound healing, reduce amputations and restore mobility for patients. This novel technology provides a new and minimally-invasive option for “no option” CLTI patients that may help them improve their lives and avoid amputation. For additional information, please visit www.limflow.com.

Critical Limb Ischemia, Wound Healing, Amputation Free, Endovascular, Perfusion, Venous Arterialization, Desert Foot, Diabetic Foot, Rutherford 5, Rutherford 6, and CLI Fighter